EUVIMEDEUVIMED entdecken
Crossref

Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuria

Masato Oguri, Yoshio Ohyama, Tetsuya Nakamura, Shoichi Tomono, Masahiko Kurabayashi

Dubai Diabetes and Endocrinology Journal · 2009

DOI: 10.1159/000497664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dubai Diabetes and Endocrinology Journal, 2009. Verfasst von Masato Oguri und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A prospective randomized open-labeled study was performed to compare the renoprotective effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients with hypertension. Diabetic patients who have hypertension and microalbuminuria at base line (n=19) were recruited. Enarapril (n=11) or losartan (n=8) was randomly chosen by envelope methods and was prescribed for one year. At the end of this study, the blood pressure of patients in these two groups decreased significantly. Urine albumin-creatinine ratio (U-ACR) also decreased in these two groups, however, U-ACR of enarapril group was not significantly different from that of losartan group at any time of this study. Body mass index, HbA1c, blood pressure, and serum lipid profiles were not significantly different between the two groups. From these results, we conclude that the effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients along with hypertension seem to be equivalent in terms of clinical renoprotection.

Zitieren

APA

Oguri, M., Ohyama, Y., Nakamura, T., Tomono, S., & Kurabayashi, M. (2009). Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuria. Dubai Diabetes and Endocrinology Journal. https://doi.org/10.1159/000497664

Vancouver

Oguri M, Ohyama Y, Nakamura T, Tomono S, Kurabayashi M. Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuria. Dubai Diabetes and Endocrinology Journal. 2009. doi:10.1159/000497664

BibTeX
@article{Oguri2009,
  author = {Oguri, Masato and Ohyama, Yoshio and Nakamura, Tetsuya and Tomono, Shoichi and Kurabayashi, Masahiko},
  title = {Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuria},
  journal = {Dubai Diabetes and Endocrinology Journal},
  year = {2009},
  doi = {10.1159/000497664}
}
Kostenlos starten →